Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

5.91
-0.6000-9.22%
Post-market: 5.910.00000.00%16:10 EDT
Volume:203.48K
Turnover:1.23M
Market Cap:201.85M
PE:-16.73
High:6.54
Open:6.46
Low:5.91
Close:6.51
52wk High:9.92
52wk Low:4.68
Shares:34.15M
Float Shares:22.75M
Volume Ratio:0.42
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3534
EPS(LYR):-0.3534
ROE:-69.06%
ROA:-7.32%
PB:5.75
PE(LYR):-16.73

Loading ...

Fennec Pharmaceuticals Inc - Pedmark Showed No Interference With Cisplatin Antitumor Activity

THOMSON REUTERS
·
Dec 02, 2025

Fennec Pharmaceuticals Inc - Study Shows Significant Reduction in Hearing Loss in 3-18 Year Olds

THOMSON REUTERS
·
Dec 02, 2025

Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss

GlobeNewswire
·
Dec 02, 2025

Fennec Pharmaceuticals Unveils Presentation Highlighting PEDMARK’s Role in Preventing Hearing Loss from Cancer Treatment

Reuters
·
Dec 01, 2025

Southpoint Capital Advisors LP Reports Disposal of Fennec Pharmaceuticals Inc. Common Shares

Reuters
·
Nov 21, 2025

Analysts Are Bullish on These Healthcare Stocks: Fennec Pharmaceuticals (FENC), Boston Scientific (BSX)

TIPRANKS
·
Nov 19, 2025

Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption

GlobeNewswire
·
Nov 19, 2025

Fennec Pharmaceuticals Highlights PEDMARK® Growth and Advances in Pediatric Cancer Care in New Corporate Presentation

Reuters
·
Nov 18, 2025

Fennec Pharmaceuticals Raises $5 Million in Canadian Private Share Offering

Reuters
·
Nov 18, 2025

Southpoint Capital Advisors Reports Sale of Fennec Pharmaceuticals Common Shares

Reuters
·
Nov 18, 2025

Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

GlobeNewswire
·
Nov 18, 2025

Fennec Pharmaceuticals Announces US$5 Million Private Share Offering in Canada

Reuters
·
Nov 14, 2025

BRIEF-Fennec Pharmaceuticals Prices 4.6 MLN Common Shares At $7.50 Per Share

Reuters
·
Nov 14, 2025

Fennec Pharmaceuticals Inc - Prices 4,666,667 Common Shares at $7.50 per Share

THOMSON REUTERS
·
Nov 14, 2025

Fennec reports Q3 EPS (2c), consensus (3c)

TIPRANKS
·
Nov 14, 2025

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

GlobeNewswire
·
Nov 14, 2025

Fennec Pharmaceuticals Reports Record Q3 Net Product Sales of $12.5 Million

Reuters
·
Nov 14, 2025

Fennec Pharmaceuticals Q3 Product Sales USD 12.5 Million

THOMSON REUTERS
·
Nov 14, 2025

Fennec Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

Fennec Pharmaceuticals Director Chris A. Rallis Reports Disposal of Common Shares

Reuters
·
Oct 15, 2025